Rubius Therapeutics (RUBY)

Trade RUBY now with
9/13/2022 8:07:48 AM Rubius Therapeutics Plans To Restructure The Company; Implementing 75% Reduction In Force
7/19/2022 7:05:40 AM HotSpot Therapeutics Appoints Jose Carmona To Board Of Directors
7/14/2022 8:07:47 AM Rubius Therapeutics Appoints Susanne Schaffert To Board
5/24/2022 8:29:09 AM Rubius Therapeutics Appoints Noubar Afeyan As Chairman Of Board Of Directors
8/30/2021 8:13:10 AM Rubius Therapeutics Appoints Jim Jogerst As Chief Business Officer
6/16/2021 8:32:45 AM RBC Global Asset Management Announces RBC ETF Cash Distributions For June
5/19/2021 9:45:37 AM Invaio Sciences Announces Agreement With Fundecitrus In Brazil To Combat Against Citrus Greening
8/13/2018 6:49:35 AM Jefferies Starts Rubius Therapeutics (RUBY) At Buy With $40 Price Target